This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Keurig Stock Rises 5% YTD: Should Investors Buy Now or Wait?
by Zacks Equity Research
KDP remains positioned for long-term growth, supported by its diversified portfolio, strong brand equity, and disciplined approach to innovation and execution.
Coca-Cola Stock Soars to a 52-Week High: Buy More or Stay Put?
by Rajani Lohia
After KO hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.
PepsiCo Trades Below 200-Day SMA: Buying Opportunity or Red Flag?
by Rajani Lohia
PEP struggles with a weak QFNA segment and North American market but may grow through effective cost management, global reach, strategic execution and industry strength.
Why Is Keurig Dr Pepper (KDP) Up 1% Since Last Earnings Report?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ETFs in Focus as PepsiCo Buys Prebiotic Soda Brand Poppi
by Sanghamitra Saha
PepsiCo acquired the prebiotic soda brand Poppi for $1.95 billion to solidify its footprint in the healthier beverage segment.
Zacks Industry Outlook Highlights Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Primo Brands
by Zacks Equity Research
Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Primo Brands are part of the Zacks Industry Outlook article.
5 Soft Drinks Stocks Showing Resilience Amid Cost & Tariff Woes
by Rajani Lohia
Beverages - Soft Drinks industry presents growth opportunities, driven by innovation and digital transformation. Yet, it grapples with cost inflation, tariff uncertainties and supply-chain challenges. Top players such as KO, PEP, MNST, KDP and PRMB stand out as strong investment options.
Coca-Cola Stock Trades Above 50 & 200-Day SMAs: Entry Point or Wait?
by Rajani Lohia
KO's strong market position and strategies fuel long-term growth, but inflation, macro risks and valuation concerns pose challenges amid economic uncertainty.
Do Options Traders Know Something About Keurig Dr Pepper (KDP) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Keurig Dr Pepper (KDP) stock based on the movements in the options market lately.
Keurig Dr Pepper's Brand Strength & Pricing Actions Seem Encouraging
by Zacks Equity Research
KDP gains from innovation and solid performance in its Refreshment Beverages segment.
Company News for Feb 26, 2025
by Zacks Equity Research
Companies in The News Are: HD,KDP,SRE,NOVT
Keurig Dr Pepper Q4 Earnings Top Estimates, Coffee Segment Sales Down
by Zacks Equity Research
KDP's fourth-quarter 2024 results benefit from continued brand strength and improvements in volume/mix performance.
Compared to Estimates, Keurig Dr Pepper (KDP) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Keurig Dr Pepper (KDP) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Keurig Dr Pepper, Inc (KDP) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Keurig Dr Pepper (KDP) delivered earnings and revenue surprises of 1.75% and 0.96%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Keurig Dr Pepper, Boston Beer, Anheuser-Busch, Monster Beverage and Fomento Economico Mexicano
by Zacks Equity Research
Keurig Dr Pepper, Boston Beer, Anheuser-Busch, Monster Beverage and Fomento Economico Mexicano are included in this Analyst Blog.
Are These 5 Beverage Stocks Poised for Earnings Beat This Season?
by Zacks Equity Research
The beverage industry players are expected to have gained from expansion, pricing and solid demand, but inflation and currency woes are likely to have posed challenges.
Unveiling Keurig Dr Pepper (KDP) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Keurig Dr Pepper (KDP) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
KDP Poised to Report Q4 Earnings: Is a Surprise in the Cards?
by Zacks Equity Research
Keurig Dr Pepper's fourth-quarter earnings are likely to have been driven by innovation, portfolio expansion and Refreshment Beverages growth.
Coca-Cola Stock Rises 7% Post Robust Q4 Results: Jump in or Wait?
by Rajani Lohia
KO's focus on core brands, innovation efforts, redefined marketing approach and digital expansion position it for long-term growth.
PepsiCo Stock Up 1.3% on Q4 Results: Bullish Signal or Caution Ahead?
by Rajani Lohia
PEP's Q4 results show weak revenues due to soft category trends in North America, recall-related issues at QFNA and business disruptions.
Coca-Cola's Growth Continues Ahead of Q4 Earnings: Time to Invest?
by Rajani Lohia
KO's fourth-quarter results are expected to reflect positive business trends, backed by a robust brand portfolio, favorable pricing/mix and revenue growth in its segments.
Lee Enterprises, Incorporated (LEE) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lee Enterprises (LEE) delivered earnings and revenue surprises of -600% and 3.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
KDP's Brands & Pricing Actions Seem Good: Apt to Hold the Stock?
by Zacks Equity Research
Keurig Dr Pepper gains from innovation and solid performance in its Refreshment Beverages segment.
PepsiCo Struggles Ahead of Q4 Earnings: Time to Invest or Stay Away?
by Rajani Lohia
PEP's Q4 results may be impacted by weak demand in North America's convenient food segment and the effects of a product recall in the QFNA division.
PepsiCo Falls 15% in 3 Months: Is it a Buy Option or Warning Sign?
by Rajani Lohia
PEP is in deep trouble due to persistent challenges in the North America business, including lower consumer demand and product recalls in the QFNA segment.